Biophysics in Drug Discovery 2017
Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Strasbourg, France June 6-9, 2017
The SCT (Société de Chimie Thérapeutique, French Society of Medicinal Chemistry) and NovAliX share a major interest in early-stage drug discovery and would like to stimulate creativity in biophysics applied to drug discovery.
As the SCT and NovAliX have developed privileged relations on the scientific level, they have decided to offer 2 joint poster prizes: the SCT-NovAliX Prizes, which will distinguish outstanding poster presentations by young researchers involving innovative methods. The prizes will be composed of a financial reward (300 Euro) as well as a free registration to RICT 2018.
Moreover, in order to support the event, the SCT will promote the NovAliX Conference "Biophysics for Drug Discovery 2017" through its own communication channels.
The SFB (Société Française de Biophysique, French Society of Biophysics) is supporting the 4th NovAliX Conference "Biophysics in Drug Discovery" and will distinguish the innovative use of biophysical methods with a poster prize (amount: 250 Euro).